Weighted Average Number of Shares Outstanding, Diluted of Kiniksa Pharmaceuticals International, plc from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Kiniksa Pharmaceuticals International, plc quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Kiniksa Pharmaceuticals International, plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 78,979,030, a 11% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 78,979,030, a 11% increase from 2024.
  • Kiniksa Pharmaceuticals International, plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 71,424,159, a 0.69% decline from 2023.
  • Kiniksa Pharmaceuticals International, plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 71,922,915, a 2.1% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Kiniksa Pharmaceuticals International, plc Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 78,979,030 +7,554,871 +11% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 80,035,400 +8,308,715 +12% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 77,942,082 +6,937,442 +9.8% 01 Apr 2025 30 Jun 2025 10-Q 29 Jul 2025 2025 Q2
Q1 2025 76,145,617 +5,512,594 +7.8% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 71,424,159 -498,756 -0.69% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 71,726,685 +1,540,669 +2.2% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025 2025 Q3
Q2 2024 71,004,640 -630,089 -0.88% 01 Apr 2024 30 Jun 2024 10-Q 29 Jul 2025 2025 Q2
Q1 2024 70,633,023 +881,326 +1.3% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025 2025 Q1
Q4 2023 71,922,915 +1,501,593 +2.1% 01 Oct 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q3 2023 70,186,016 -366,002 -0.52% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024 2024 Q3
Q2 2023 71,634,729 +2,344,757 +3.4% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024 2024 Q2
Q1 2023 69,751,697 +614,796 +0.89% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q4 2022 70,421,322 +1,844,512 +2.7% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 70,552,018 +1,889,345 +2.8% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 69,289,972 +894,269 +1.3% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 69,136,901 +867,415 +1.3% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 68,576,810 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 68,662,673 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 68,395,703 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 68,269,486 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1

Kiniksa Pharmaceuticals International, plc Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 78,979,030 +7,554,871 +11% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 71,424,159 -498,756 -0.69% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 71,922,915 +1,501,593 +2.1% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 70,421,322 +1,844,512 +2.7% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 68,576,810 +6,734,088 +11% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 61,842,722 +7,793,245 +14% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023 2022 FY
2019 54,049,477 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.